Back
Eversource Energy 10K Form
Buy
56
ES
Eversource Energy
Last Price:
67.56
Seasonality Move:
2.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-07 | 10Q | ES/Eversource Energy Quarterly |
2023-08-04 | 10Q | ES/Eversource Energy Quarterly |
2023-05-05 | 10Q | ES/Eversource Energy Quarterly |
2022-11-04 | 10Q | ES/Eversource Energy Quarterly |
2022-08-04 | 10Q | ES/Eversource Energy Quarterly |
2022-05-06 | 10Q | ES/Eversource Energy Quarterly |
Receive ES News And Ratings
See the #1 stock for the next 7 days that we like better than ES
ES Financial Statistics
Sales & Book Value
Annual Sales: | $11.91B |
---|---|
Cash Flow: | $-400.76M |
Price / Cash Flow: | 0 |
Annual Sales: | $41.79 |
Price / Book: | 1.63 |
Profitability
EPS (TTM): | -0.27000 |
---|---|
Net Income (TTM): | $-91.63M |
Gross Margin: | $4.85B |
Return on Equity: | -0.61% |
Return on Assets: | -0.16% |
Eversource Energy Earnings Forecast
Key Eversource Energy Financial Ratios
- The Gross Profit Margin over the past 30 years for ES is 40.69%.
- The Selling, General & Administrative Expenses for ES have been equal to -1.12% of Gross Profit Margin.
- The Research & Development expenses have been 6.20% of Revenue.
- The Interest Expense is -193.43% of Operating Income.
- The Net Earning history of ES is -3.71% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 20 years.
Eversource Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Electric Utilities |
Sector: | Utilities |
Current Symbol: | ES |
CUSIP: | 30040W |
Website: | eversource.com |
Debt
Debt-to-Equity Ratio: | 1.95 |
---|---|
Current Ratio: | 0.75 |
Quick Ratio: | 0.27 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 14.05 |
ES Technical Analysis vs Fundamental Analysis
Buy
56
Eversource Energy (ES)
is a Buy
Is Eversource Energy a Buy or a Sell?
-
Eversource Energy stock is rated a Buy
The current Eversource Energy [ES] share price is $67.52. The Score for ES is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.